Brompheniramine recalls
The FDA has published 4 recalls involving Brompheniramine since 2015. The latest was reported on 2 Jun 2021. Most were for sterility. Cardinal Health has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls4since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 100%Class III 0 0%
Why brompheniramine is recalled
Companies
By year
All brompheniramine recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Brompheniramine Maleate, Pseudoephedrine Hydrochloride recalledBrompheniramine Maleate, Pseudoephedrine Hydrochloride | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Brompheniramine Maleate, Pseudoephedrine Hydrochloride recalled | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Brompheniramine Maleate (10 mg/mL) Multi-Dose Vial recalled | US Compounding | Sterility | Nationwide |
| Drug | CLASS II | Brompheniramine Maleate 20 mg/ml Injectable, Vial, Sterile recalled | The Compounding Pharmacy of America | Sterility | Nationwide |
Should you stop taking Brompheniramine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.